Loading...
Akso Health Group
AHG•NASDAQ
Financial ServicesFinancial - Credit Services
$1.37
$-0.08(-5.52%)
Akso Health Group (AHG) Financial Performance & Statements
Review Akso Health Group’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-81.68%
↓ 81.68%
Operating Income Growth
39.45%
↑ 39.45%
Net Income Growth
27.71%
↑ 27.71%
Operating Cash Flow Growth
141.53%
↑ 141.53%
Operating Margin
-415.73%
↓ 415.73%
Gross Margin
5.48%
↑ 5.48%
Net Profit Margin
-394.41%
↓ 394.41%
ROE
-4.33%
↓ 4.33%
ROIC
-4.57%
↓ 4.57%
Akso Health Group (AHG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Akso Health Group stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $760377.00 | $760377.00 | $446792.00 | $446792.00 |
| Cost of Revenue | $718726.00 | $718726.00 | $427377.00 | $427377.00 |
| Gross Profit | $41651.00 | $41651.00 | $19415.00 | $19415.00 |
| Gross Profit Ratio | $0.05 | $0.05 | $0.04 | $0.04 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.20M | $3.20M | $1.18M | $1.18M |
| Operating Expenses | $3.20M | $3.07M | $1.54M | $1.54M |
| Total Costs & Expenses | $3.92M | $3.79M | $1.97M | $1.97M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $3.16M | $3.16M | $1.16M | $1.16M |
| EBITDA | $0.00 | $163750.00 | -$361729.00 | -$361729.00 |
| EBITDA Ratio | $0.00 | $0.22 | -$0.81 | -$0.81 |
| Operating Income | -$3.16M | -$3.16M | -$1.16M | -$1.16M |
| Operating Income Ratio | -$4.16 | -$4.16 | -$2.59 | -$2.59 |
| Other Income/Expenses (Net) | $134534.00 | $134534.00 | -$361410.00 | -$361410.00 |
| Income Before Tax | -$3.03M | -$3.03M | -$1.52M | -$1.52M |
| Income Before Tax Ratio | -$3.98 | -$3.98 | -$3.40 | -$3.40 |
| Income Tax Expense | $59.00 | $59.00 | $12435.00 | $12435.00 |
| Net Income | -$3.001M | -$3.00M | -$1.53M | -$1.53M |
| Net Income Ratio | -$3.95 | -$3.94 | -$3.43 | -$3.43 |
| EPS | -$0.05 | -$0.05 | -$0.07 | -$0.07 |
| Diluted EPS | -$0.04 | -$0.04 | -$0.07 | -$0.07 |
| Weighted Avg Shares Outstanding | $62.44M | $62.38M | $22.87M | $22.87M |
| Weighted Avg Shares Outstanding (Diluted) | $71.48M | $71.48M | $22.87M | $22.87M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan